Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
NCT04433481Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in portal vein thrombosis (PVT) comparing DABIGATRAN with Placebo (2 arms). Primary endpoint: Complete recanalization of thrombus at 1 year. Status: unknown.
02
Drugs
dabigatran
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT04433481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433481.